Pregnenolone-progesterone-allopregnanolone pathway as a potential therapeutic target in first-episode antipsychotic-naive patients with schizophrenia
Home »
Publications » Pregnenolone-progesterone-allopregnanolone pathway as a potential therapeutic target in first-episode antipsychotic-naive patients with schizophrenia
Publish Date 06/06/2024
Category
Keywords
Pregnenolone-progesterone-allopregnanolone pathway as a potential therapeutic target in first-episode antipsychotic-naive patients with schizophrenia
Join the Arbor Assays Newsletter
Sign up for Arbor Assays’ email list to stay up to date on special deals, new kits, and published articles featuring Arbor Assays’ products
